PAX2 Gene Focal segmental glomerulosclerosis type 7 Genetic Test
Test Name: PAX2 Gene Focal segmental glomerulosclerosis type 7 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PAX2 Gene Focal segmental glomerulosclerosis type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PAX2 Gene Focal segmental glomerulosclerosis type 7 NGS Genetic DNA Test gene PAX2
Test Details
The PAX2 gene is associated with the development of focal segmental glomerulosclerosis (FSGS), a kidney disorder characterized by scarring of the glomeruli (the filtering units of the kidneys). FSGS can lead to kidney damage and eventually kidney failure.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any genetic variants or mutations that may be present. In the case of FSGS, an NGS genetic test can be performed to analyze the PAX2 gene and identify any variants or mutations that may be associated with the development of the condition.
The specific term “Focal segmental glomerulosclerosis type 7” refers to a specific subtype of FSGS that is caused by mutations in the PAX2 gene. The NGS genetic test for FSGS type 7 would specifically focus on analyzing the PAX2 gene for any mutations or variants that may be associated with this subtype of the condition.
Genetic testing for FSGS can be helpful in diagnosing the condition, understanding its genetic basis, and providing information for personalized treatment and management plans. It can also be useful for identifying individuals who may be at risk of developing FSGS and for genetic counseling purposes.
| Test Name | PAX2 Gene Focal segmental glomerulosclerosis type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PAX2 Gene Focal segmental glomerulosclerosis type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PAX2 Gene Focal segmental glomerulosclerosis type 7 NGS Genetic DNA Test gene PAX2 |
| Test Details |
The PAX2 gene is associated with the development of focal segmental glomerulosclerosis (FSGS), a kidney disorder characterized by scarring of the glomeruli (the filtering units of the kidneys). FSGS can lead to kidney damage and eventually kidney failure. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any genetic variants or mutations that may be present. In the case of FSGS, an NGS genetic test can be performed to analyze the PAX2 gene and identify any variants or mutations that may be associated with the development of the condition. The specific term “Focal segmental glomerulosclerosis type 7” refers to a specific subtype of FSGS that is caused by mutations in the PAX2 gene. The NGS genetic test for FSGS type 7 would specifically focus on analyzing the PAX2 gene for any mutations or variants that may be associated with this subtype of the condition. Genetic testing for FSGS can be helpful in diagnosing the condition, understanding its genetic basis, and providing information for personalized treatment and management plans. It can also be useful for identifying individuals who may be at risk of developing FSGS and for genetic counseling purposes. |
